2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
about
SEOM Clinical Guideline update for the prevention of chemotherapy-induced nausea and vomiting (2016).Differential clinical pharmacology of rolapitant in delayed chemotherapy-induced nausea and vomiting (CINV)Risk factors for delayed chemotherapy-induced nausea and vomiting with low-emetic-risk chemotherapy: a prospective, observational, multicenter study
P2860
2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
2016 Updated MASCC/ESMO Consen ...... w or minimal emetic potential.
@en
type
label
2016 Updated MASCC/ESMO Consen ...... w or minimal emetic potential.
@en
prefLabel
2016 Updated MASCC/ESMO Consen ...... w or minimal emetic potential.
@en
P2093
P2860
P1476
2016 Updated MASCC/ESMO Consen ...... w or minimal emetic potential.
@en
P2093
Cynthia N Rittenberg
Franziska Jahn
Lee Schwartzberg
Rebecca Clark-Snow
P2860
P2888
P304
P356
10.1007/S00520-016-3391-Z
P577
2016-08-30T00:00:00Z